Arcus biosciences to participate in the evercore isi 3rd annual healthconx virtual conference

Hayward, calif.--(business wire)--arcus biosciences, inc. (nyse:rcus), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that management will present at the evercore isi 3rd annual healthconx virtual conference on wednesday, december 2, 2020 at 10:30 a.m. eastern time. a live audio webcast of the presentation will be available by visiting the “investors” section of the arcus website at www.arcusbio.com. a replay of the webcast will b
RCUS Ratings Summary
RCUS Quant Ranking